The joint venture with PeopleMed.com will allow us to create one of the most advanced software applications for asthma and COPD disease management programs, reaching even more patients and providing them with critical information about their health. said David Tinkelman, MD, vice-president of health initiatives for National Jewish in a media release.
The collaboration will allow PeopleMed to have access to National Jewish’s intellectual property, with respect to respiratory illnesses. All medical information will be integrated into PeopleMed’s proprietary DyniSoft(TM) suite of Internet-based disease management products.
Once this information is incorporated into our Application Service Provider (ASP) model, PeopleMed’s DyniSoft suite of products will be able to assist medical professionals in the diagnosis and management of both asthma and COPD, said Michael I. Ruxin, MD, chairman and CEO of Global Med Technologies and PeopleMed.com. Ultimately, this program will allow physicians, HMOs, health plans, Medicaid agencies, nursing homes, at risk employers and disease management companies to have the preeminent in-house disease management program that will greatly improve the quality of life of patients and keep costs down.
